Yoichi Naritomi

644 total citations
17 papers, 496 citations indexed

About

Yoichi Naritomi is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Yoichi Naritomi has authored 17 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Yoichi Naritomi's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (12 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Yoichi Naritomi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (12 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Yoichi Naritomi collaborates with scholars based in Japan and United States. Yoichi Naritomi's co-authors include Shigeyuki Terashita, Akira Kagayama, Yuichi Sugiyama, Shigeru Ohta, Seigo Sanoh, Kenji Tabata, Toshio Teramura, Katsuhiro Yamano, Hiroyuki Moriguchi and Kazuhiro Tetsuka and has published in prestigious journals such as British Journal of Pharmacology, Bioorganic & Medicinal Chemistry and Drug Metabolism and Disposition.

In The Last Decade

Yoichi Naritomi

17 papers receiving 488 citations

Peers

Yoichi Naritomi
Jasleen K. Sodhi United States
Anna-Karin Sohlenius-Sternbeck Sweden
Peter Kilford United Kingdom
Nancy Hakooz Jordan
Kunihiro Yoshisue Japan
Setsuko Komuro Japan
Kenji Tabata Japan
Masaki Kumondai Japan
Ken‐ichi Nunoya Japan
Renato J. Scialis United States
Jasleen K. Sodhi United States
Yoichi Naritomi
Citations per year, relative to Yoichi Naritomi Yoichi Naritomi (= 1×) peers Jasleen K. Sodhi

Countries citing papers authored by Yoichi Naritomi

Since Specialization
Citations

This map shows the geographic impact of Yoichi Naritomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Naritomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Naritomi more than expected).

Fields of papers citing papers by Yoichi Naritomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichi Naritomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Naritomi. The network helps show where Yoichi Naritomi may publish in the future.

Co-authorship network of co-authors of Yoichi Naritomi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichi Naritomi. A scholar is included among the top collaborators of Yoichi Naritomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichi Naritomi. Yoichi Naritomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Naritomi, Yoichi, Yoshitaka Hashimoto, Takeshi Hanada, et al.. (2022). Understanding quantitative polymerase chain reaction bioanalysis issues before validation planning: Japan Bioanalysis Forum discussion group. Bioanalysis. 14(21). 1391–1405. 5 indexed citations
2.
3.
Naritomi, Yoichi, Seigo Sanoh, & Shigeru Ohta. (2019). Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with <i>in Vitro</i>–<i>in Vivo</i> Extrapolation and Allometric Scaling. Biological and Pharmaceutical Bulletin. 42(3). 327–336. 16 indexed citations
4.
Naritomi, Yoichi, Seigo Sanoh, & Shigeru Ohta. (2017). Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery. Drug Metabolism and Pharmacokinetics. 33(1). 31–39. 36 indexed citations
5.
Sanoh, Seigo, Yoichi Naritomi, Akio Kawamura, et al.. (2015). Predictability of plasma concentration–time curves in humans using single-species allometric scaling of chimeric mice with humanized liver. Xenobiotica. 45(7). 605–614. 41 indexed citations
6.
Naritomi, Yoichi, et al.. (2014). Prediction of hepatic and intestinal glucuronidation using in vitro–in vivo extrapolation. Drug Metabolism and Pharmacokinetics. 30(1). 21–29. 26 indexed citations
7.
Watanabe, Kazushi, Akio Kakefuda, Minoru Yasuda, et al.. (2013). Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: A novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitor. Bioorganic & Medicinal Chemistry. 21(17). 5261–5270. 9 indexed citations
8.
Naritomi, Yoichi, Kazuhiro Tetsuka, Hiroyuki Moriguchi, et al.. (2013). Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys. Xenobiotica. 44(3). 205–216. 22 indexed citations
9.
10.
Yamano, Katsuhiro, et al.. (2012). Method for predicting human intestinal first-pass metabolism of UGT substrate compounds. Xenobiotica. 42(10). 980–988. 8 indexed citations
11.
Naritomi, Yoichi, Ken‐ichi Hosoya, Hiroyuki Moriguchi, et al.. (2012). Quantitative Prediction of Human Intestinal Glucuronidation Effects on Intestinal Availability of UDP-Glucuronosyltransferase Substrates Using In Vitro Data. Drug Metabolism and Disposition. 40(9). 1771–1777. 10 indexed citations
12.
Naritomi, Yoichi, et al.. (2011). Correlation of Intrinsic in vitro and in vivo Clearance for Drugs Metabolized by Hepatic UDP-glucuronosyltransferases in Rats. Drug Metabolism and Pharmacokinetics. 26(5). 465–473. 14 indexed citations
13.
Gerst, Nicolas, et al.. (2011). A Practical and Direct Comparison of Intrinsic Metabolic Clearance of Several Non-CYP Enzyme Substrates in Freshly Isolated and Cryopreserved Hepatocytes. Drug Metabolism and Pharmacokinetics. 27(2). 181–191. 22 indexed citations
14.
Tetsuka, Kazuhiro, Yoichi Naritomi, Hiroyuki Moriguchi, et al.. (2011). Quantitative Prediction of Intestinal Glucuronidation of Drugs in Rats Using In Vitro Metabolic Clearance Data. Drug Metabolism and Pharmacokinetics. 27(2). 171–180. 18 indexed citations
15.
Ishikawa, Takeshi, Fusako Nishigaki, Susumu Miyata, et al.. (2004). Prevention of progressive joint destruction in collagen‐induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. British Journal of Pharmacology. 144(1). 133–143. 49 indexed citations
16.
17.
Naritomi, Yoichi, Shigeyuki Terashita, Akira Kagayama, & Yuichi Sugiyama. (2003). Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro. Drug Metabolism and Disposition. 31(5). 580–588. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasleen K. Sodhi Breakdown of academic impact, for papers by Anna-Karin Sohlenius-Sternbeck Breakdown of academic impact, for papers by Peter Kilford Breakdown of academic impact, for papers by Nancy Hakooz Breakdown of academic impact, for papers by Kunihiro Yoshisue Breakdown of academic impact, for papers by Setsuko Komuro Breakdown of academic impact, for papers by Kenji Tabata Breakdown of academic impact, for papers by Masaki Kumondai Breakdown of academic impact, for papers by Ken‐ichi Nunoya Breakdown of academic impact, for papers by Renato J. Scialis
Rankless by CCL
2026